Related Experiment Video
Updated: May 26, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
General analysis of competitive binding in drug-interceptor-DNA systems
A S Buchelnikov1, A A Hernandez Santiago, M Gonzalez Flores
1Department of Physics, Sevastopol National Technical University, Universitetskaya str., 33, Sevastopol 99053, Ukraine.
European Biophysics Journal : EBJ
|January 4, 2012
Summary
A new model quantifies drug-DNA interactions, revealing the crucial role of protector mechanisms, even when drug-DNA binding is weak. This helps understand drug efficacy and competition. Keywords: drug-DNA binding, protector mechanism, competitive binding model.
Area of Science:
- Molecular Biology
- Pharmacology
- Biophysics
Background:
- Drug-DNA interactions are complex, involving competition between drugs, interceptors, and DNA.
- Existing models often simplify these interactions, potentially overlooking key mechanisms like protection.
- Understanding these dynamics is crucial for drug development and predicting drug efficacy.
Purpose of the Study:
- To develop a general mathematical model for competitive binding in drug-interceptor-DNA systems.
- To quantify both interceptor and protector mechanisms in these systems.
- To provide a framework that incorporates existing models as special cases.
Main Methods:
- Developed a general model with full parameterization of binding equations.
- Incorporated statistical effects using the McGhee-von Hippel formalism.
- Accounted for hetero-association between drugs and interceptors, including self- and hetero-complexes.
Main Results:
- The model successfully quantifies both interceptor and protector mechanisms.
- It integrates various existing models as partial cases.
- Indirect evidence highlights the significance of the protector mechanism in drug-caffeine-DNA systems, even with low caffeine-DNA binding constants.
Conclusions:
- The developed model offers a comprehensive approach to understanding drug-DNA competitive binding.
- Protector mechanisms play a vital role and should not be overlooked, even with weak direct binding.
- This framework advances the quantitative analysis of drug-DNA interactions and their modulation.
Related Concept Videos
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
02:18The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
01:22Protein-Drug Binding: Determination Methods
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
02:13Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...